RICI HEALTH 01526·

Gross margin 41.02%--39.04%1.98%41.75%2.71%39.93%1.82%43.19%3.26% Net margin 5.30%--11.25%5.95%13.43%2.18%12.13%1.30%13.70%1.57% ROE 26.80%--30.48%3.69%32.28%1.80%22.09%10.19%18.66%3.43% ROA 2.78%--5.85%3.07%8.67%2.82%7.30%1.37%7.85%0.55% Revenue growth -----0.09%--26.01%26.10%-2.28%28.29%-4.41%2.13% Attributable profit growth ----60.17%--25.11%35.06%-18.27%43.38%3.30%21.57% Debt-to-assets 87.05%--80.19%6.86%75.98%4.21%71.70%4.28%64.75%6.95% Current ratio 0.71--0.630.080.660.030.840.170.980.14 Operating cash flow / net profit 5.40--2.642.762.060.592.230.171.880.35 Operating cash flow / revenue 28.65%--29.74%1.09%27.61%2.13%27.03%0.58%25.73%1.30%

Gross margin 35.60%--34.88%0.72% Net margin 6.97%--5.72%1.24% Revenue growth -----0.55%-- Attributable profit growth -----18.58%-- Debt-to-assets ----63.76%-- Current ratio ----0.95--

Revenue 2.38B--2.38B0.09%2.99B26.01%2.92B2.28%2.80B4.41% Other income and gains 20.18M--22.04M9.22%26.63M20.83%47.68M79.06%25.30M46.94% Gross profit 975.22M--927.20M4.92%1.25B34.76%1.17B6.54%1.21B3.39% Selling and distribution expenses 252.21M--286.84M13.73%380.58M32.68%301.85M20.69%323.80M7.27% Administrative expenses 219.14M--222.41M1.50%223.84M0.64%265.14M18.45%221.42M16.49% Net finance costs 132.05M--111.33M15.70%122.62M10.14%128.85M5.08%103.55M19.63% Income tax 98.37M--84.04M14.57%143.66M70.94%129.27M10.02%184.31M42.58% Operating profit 516.38M--431.68M16.40%656.92M52.18%607.50M7.52%665.08M9.48% Profit before tax 392.07M--327.19M16.55%545.63M66.76%483.92M11.31%567.34M17.24% Net profit 126.11M--267.19M111.88%401.98M50.45%354.65M11.77%383.03M8.00% Net profit attributable to owners 181.55M--290.79M60.17%363.80M25.11%297.32M18.27%307.13M3.30%

Revenue 1.14B--1.14B0.55% Other income and gains 20.98M--23.22M10.68% Cost of sales 737.26M--741.48M0.57% Gross profit 407.59M--397.10M2.57% Selling and distribution expenses 134.47M--190.28M41.51% Administrative expenses 116.74M--105.83M9.34% Net finance costs 50.09M--43.86M12.42% Income tax 39.70M--23.14M41.70% Operating profit 168.96M--132.47M21.60% Share of associates and JVs 568.00K---330.00K158.10% Profit before tax 119.44M--88.28M26.09% Net profit 79.75M--65.14M18.32% Net profit attributable to owners 55.94M--45.55M18.58%

Cash and cash equivalents 771.26M--720.14M6.63%811.21M12.65%1.11B36.81%1.14B2.31% Trade and bills receivables 346.32M--278.71M19.52%299.47M7.45%324.06M8.21%286.06M11.73% Inventories 50.99M--38.73M24.06%37.40M3.44%35.96M3.83%29.39M18.26% Total current assets 1.44B--1.36B5.92%1.44B6.07%1.67B15.89%1.75B5.17% Total assets 4.54B--4.57B0.68%4.64B1.55%4.86B4.76%4.88B0.41% Total current liabilities 2.03B--2.15B6.10%2.17B0.53%1.99B8.07%1.80B9.68% Total liabilities 3.95B--3.66B7.26%3.52B3.78%3.48B1.15%3.16B9.32% Equity attributable to owners 677.50M--953.92M40.80%1.13B18.14%1.35B19.42%1.65B22.31% Total equity 587.43M--904.83M54.03%1.11B23.12%1.38B23.44%1.72B25.06%

Cash and cash equivalents ----1.07B-- Trade and bills receivables ----247.40M-- Inventories ----26.86M-- Total current assets ----1.62B-- Total assets ----4.70B-- Total current liabilities ----1.70B-- Total liabilities ----2.99B-- Equity attributable to owners ----1.68B-- Total equity ----1.70B--

Net cash from operating activities 681.07M--706.37M3.71%826.29M16.98%790.58M4.32%719.39M9.00% Net cash from investing activities -269.13M---273.99M1.80%-147.00M46.35%-140.02M4.75%-301.48M115.31% Net cash from financing activities -193.99M---495.23M155.29%-592.72M19.69%-351.23M40.74%-388.92M10.73% Net change in cash 217.95M---62.85M128.84%86.57M237.75%299.32M245.76%28.99M90.32%